Infographic: Mechanisms of Resistance

Cancers appear to be able to evolve resistance to many of the therapies doctors have tried.

By | April 1, 2017

Primary Versus Acquired Resistance

Cancer cells can evolve ways to evade a drug’s attack, or they may already be resistant prior to treatment.


Examples of Acquired Resistance

Resistance to chemotherapy likely encompasses a broad range of mechanisms having to do with DNA repair, cell cycle arrest, apoptotic pathways, and others, many of which are still unknown. When it comes to molecular-targeted agents and immunotherapies, however, research has nailed down some basic strategies.


Mutations within the target protein can prevent drug binding, or keep the protein active despite drug binding.


Mutations can restore cellular signaling by affecting a downstream gene or by activating a bypass pathway.


Tumor cells can lose characteristics of their typical cell type and acquire characteristics of a different lineage that does not depend on signaling blocked by the cancer drug.


Mutations can render tumor cells less recognizable to the immune system or less responsive to molecular signals from immune cells.


Mutations and other changes alter the target protein. These can include altered splicing of the tumor target, which blocks recognition by the engineered T cell.

Read the full story


Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Man Receives First In Vivo Gene-Editing Therapy
  2. Researchers Build a Cancer Immunotherapy Without Immune Cells
  3. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

  4. Long-term Study Finds That the Pesticide Glyphosate Does Not Cause Cancer